ATX-304

Mitochondrial / Longevity

Cellular resilience and longevity positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Small molecule
Primary mechanism: Mitochondrial and metabolic modulation
Primary market use: Longevity

Pharmacology

Molecular weight (Da): Not established
Oral bioavailability: Unknown
Half-life: ~2–12 h small-molecule class estimate
Route tags: Route-dependent / verify
Evidence level: Research
Clinical status: Experimental
Value-for-money score: 4 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Evidence limited

Sources

https://pubmed.ncbi.nlm.nih.gov/